Title:Validation and Development of N-glycan as Biomarker in Cancer Diagnosis
VOLUME: 11 ISSUE: 1
Author(s):Wei Wang
Affiliation:School of Medical Sciences, Edith Cowan University, Perth WA 6027, Australia
Keywords:Cancer biomarker, glycomics, N-glycan, oligosaccharide, personalized medicine, public health pharmacogenomics.
Abstract:Glycosylation, linking the glycan chains to protein or lipid, is the most common and complex post-translational
modifications of proteins. One of the important functions of glycoprotein is to maintain the ordered social life of each cell
in multicellular organisms. Glycosylation is sensitive to the biochemical environment leading to the alteration of glycan
chains under the physiological condition and specific diseases such as cancer. Cancer and other lethal diseases cannot be
diagnosed at early stage due to classic biomarker’s low sensitivity and specificity. Recently, the development of glycan
profiling technologies has offered great promises for understanding the complex glycan structures and has increased
interest in applying this technology for cancer studies. In this regard, to identify the glycans as the potential biomarkers of
cancer has become an important direction for clinical cancer diagnosis. This paper summarizes the current research on
validating and developing of the glycans as new cancer biomarkers and the nascent field of glycomics
